Technical Analysis for AMRN - Amarin Corporation plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Historical AMRN trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Reversal New Lows Setup | Bearish Swing Setup | 2.82% | |
| Lower Bollinger Band Walk | Weakness | 2.82% | |
| Outside Day | Range Expansion | 2.82% | |
| Below Lower BB | Weakness | 2.82% | |
| Lower Bollinger Band Touch | Weakness | 2.82% | |
| Oversold Stochastic | Weakness | 2.82% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Possible Inside Day | 2 days ago |
| 60 Minute Opening Range Breakout | 2 days ago |
| Up 3% | 2 days ago |
| Up 2% | 2 days ago |
| Up 1% | 2 days ago |
Get a Trading Sidekick!
- Earnings date: 04/29/2021
Amarin Corporation plc Description
Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids. The company lead product comprises Vascepa, a prescription-only omega-3 fatty acid comprising icosapent ethyl as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It also engages in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is headquartered in Dublin, Ireland.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Acid Organic Compounds Therapeutic Product Lipid Therapeutic Products Cardiovascular Disease Acids Nutrition Vascular Diseases Cardiovascular Diseases Cholesterol Icos Fatty Acid Lipoprotein Fatty Acids Lipids Triglyceride Low Density Lipoprotein Hypertriglyceridemia Polyunsaturated Fat Saturated Fat
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.24 |
| 52 Week Low | 3.36 |
| Average Volume | 5,138,308 |
| 200-Day Moving Average | 5.64 |
| 50-Day Moving Average | 5.58 |
| 20-Day Moving Average | 4.86 |
| 10-Day Moving Average | 4.58 |
| Average True Range | 0.26 |
| ADX | 32.03 |
| +DI | 10.70 |
| -DI | 31.04 |
| Chandelier Exit (Long, 3 ATRs ) | 4.68 |
| Chandelier Exit (Short, 3 ATRs ) | 4.95 |
| Upper Bollinger Band | 5.49 |
| Lower Bollinger Band | 4.22 |
| Percent B (%b) | 0.12 |
| BandWidth | 26.04 |
| MACD Line | -0.36 |
| MACD Signal Line | -0.34 |
| MACD Histogram | -0.0202 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.73 | ||||
| Resistance 3 (R3) | 4.71 | 4.58 | 4.67 | ||
| Resistance 2 (R2) | 4.58 | 4.49 | 4.59 | 4.65 | |
| Resistance 1 (R1) | 4.48 | 4.44 | 4.53 | 4.50 | 4.63 |
| Pivot Point | 4.35 | 4.35 | 4.38 | 4.36 | 4.35 |
| Support 1 (S1) | 4.25 | 4.26 | 4.30 | 4.27 | 4.13 |
| Support 2 (S2) | 4.12 | 4.21 | 4.13 | 4.11 | |
| Support 3 (S3) | 4.02 | 4.12 | 4.09 | ||
| Support 4 (S4) | 4.04 |
